141 related articles for article (PubMed ID: 11992753)
1. Phenotypic spectrum of Salla disease, a free sialic acid storage disorder.
Varho TT; Alajoki LE; Posti KM; Korhonen TT; Renlund MG; Nyman SR; Sillanpää ML; Aula PP
Pediatr Neurol; 2002 Apr; 26(4):267-73. PubMed ID: 11992753
[TBL] [Abstract][Full Text] [Related]
2. An Italian severe Salla disease variant associated with a SLC17A5 mutation earlier described in infantile sialic acid storage disease.
Biancheri R; Verbeek E; Rossi A; Gaggero R; Roccatagliata L; Gatti R; van Diggelen O; Verheijen FW; Mancini GM
Clin Genet; 2002 Jun; 61(6):443-7. PubMed ID: 12121352
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive profiles in Salla disease.
Alajoki L; Varho T; Posti K; Aula P; Korhonen T
Dev Med Child Neurol; 2004 Dec; 46(12):832-7. PubMed ID: 15581157
[TBL] [Abstract][Full Text] [Related]
4. Novel form of intermediate salla disease: clinical and neuroimaging features.
Morse RP; Kleta R; Alroy J; Gahl WA
J Child Neurol; 2005 Oct; 20(10):814-6. PubMed ID: 16417876
[TBL] [Abstract][Full Text] [Related]
5. Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.
Biancheri R; Rossi A; Verbeek HA; Schot R; Corsolini F; Assereto S; Mancini GM; Verheijen FW; Minetti C; Filocamo M
Neurogenetics; 2005 Dec; 6(4):195-9. PubMed ID: 16170568
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity.
Kleta R; Morse RP; Orvisky E; Krasnewich D; Alroy J; Ucci AA; Bernardini I; Wenger DA; Gahl WA
Mol Genet Metab; 2004 Jun; 82(2):137-43. PubMed ID: 15172001
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.
Aula N; Salomäki P; Timonen R; Verheijen F; Mancini G; Månsson JE; Aula P; Peltonen L
Am J Hum Genet; 2000 Oct; 67(4):832-40. PubMed ID: 10947946
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred.
Landau D; Cohen D; Shalev H; Pinsk V; Yerushalmi B; Zeigler M; Birk OS
Mol Genet Metab; 2004 Jun; 82(2):167-72. PubMed ID: 15172005
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children.
Kleta R; Aughton DJ; Rivkin MJ; Huizing M; Strovel E; Anikster Y; Orvisky E; Natowicz M; Krasnewich D; Gahl WA
Am J Med Genet A; 2003 Jul; 120A(1):28-33. PubMed ID: 12794688
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid storage disease of the Salla phenotype in American monozygous twin female sibs.
Martin RA; Slaugh R; Natowicz M; Pearlman K; Orvisky E; Krasnewich D; Kleta R; Huizing M; Gahl WA
Am J Med Genet A; 2003 Jul; 120A(1):23-7. PubMed ID: 12794687
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the molecular pathogenesis of free sialic acid storage disorders: altered targeting of mutant sialin.
Aula N; Jalanko A; Aula P; Peltonen L
Mol Genet Metab; 2002; 77(1-2):99-107. PubMed ID: 12359136
[TBL] [Abstract][Full Text] [Related]
12. Free sialic acid storage (Salla) disease in Sweden.
Erikson A; Aula N; Aula P; Månsson JE
Acta Paediatr; 2002; 91(12):1324-7. PubMed ID: 12578289
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of free sialic acid storage disorders (SASD).
Aula N; Aula P
Prenat Diagn; 2006 Aug; 26(8):655-8. PubMed ID: 16715535
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Characterization of the Clinical Course of Intermediate-Severe Salla Disease.
Chapleau A; Mirchi A; Tran LT; Poulin C; Bernard G
Pediatr Neurol; 2023 Nov; 148():133-137. PubMed ID: 37713976
[TBL] [Abstract][Full Text] [Related]
15. A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease.
Barmherzig R; Bullivant G; Cordeiro D; Sinasac DS; Blaser S; Mercimek-Mahmutoglu S
Pediatr Neurol; 2017 Sep; 74():87-91.e2. PubMed ID: 28662915
[TBL] [Abstract][Full Text] [Related]
16. Free sialic acid storage disorder: Progress and promise.
Huizing M; Hackbarth ME; Adams DR; Wasserstein M; Patterson MC; Walkley SU; Gahl WA;
Neurosci Lett; 2021 Jun; 755():135896. PubMed ID: 33862140
[TBL] [Abstract][Full Text] [Related]
17. Free sialic acid storage disease without sialuria.
Mochel F; Yang B; Barritault J; Thompson JN; Engelke UF; McNeill NH; Benko WS; Kaneski CR; Adams DR; Tsokos M; Abu-Asab M; Huizing M; Seguin F; Wevers RA; Ding J; Verheijen FW; Schiffmann R
Ann Neurol; 2009 Jun; 65(6):753-7. PubMed ID: 19557856
[TBL] [Abstract][Full Text] [Related]
18. Identification of a large intronic transposal insertion in SLC17A5 causing sialic acid storage disease.
Tarailo-Graovac M; Drögemöller BI; Wasserman WW; Ross CJ; van den Ouweland AM; Darin N; Kollberg G; van Karnebeek CD; Blomqvist M
Orphanet J Rare Dis; 2017 Feb; 12(1):28. PubMed ID: 28187749
[TBL] [Abstract][Full Text] [Related]
19. Salla disease in Turkish children: severe and conventional type.
Coker M; Kalkan-Uçar S; Kitiş O; Uçar H; Gökşen-Simşek D; Darcan S; Gökben S
Turk J Pediatr; 2009; 51(6):605-9. PubMed ID: 20196397
[TBL] [Abstract][Full Text] [Related]
20. A vesicular transporter that mediates aspartate and glutamate neurotransmission.
Miyaji T; Omote H; Moriyama Y
Biol Pharm Bull; 2010; 33(11):1783-5. PubMed ID: 21048299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
